| Date | Title | Description |
| 05.02.2024 | Matisse Pharmaceuticals meets primary objectives in study with M6229 in critically ill sepsis patients. | Geleen, January 30, 2024.
, a clinical stage company developing a medicinal product for the treatment of sepsis, today announced topline results from the HistoSeps trial evaluating the safety, tolerability and pharmacokinetics of intraveno... |
| 05.02.2024 | Funding of Ioniqa’s enhanced recycling business of PET Polyester | Eindhoven, 23 January 2024
is pleased to announce a significant growth investment by
to help accelerate the scale-up and roll out of its enhanced PET Polyester recycling technology.
Ioniqa’s innovative technology upcycles low-grade post-... |
| 05.02.2024 | Verdify secures €2.4 million investment for impactful food choices in healthcare and retail | Venlo & Deventer, Netherlands, 24 January 2024
has successfully raised €2.4 million in funding to scale its personalised nutrition innovation for fostering human and planetary health. The investment comes from existing shareholders and... |
| 11.01.2024 | Qorium lands additional funds from Brightlands Venture Partners and Sofinnova Partners, as the company sets out on an ambitious growth drive for sustainable leather, with the appointment of CEO Michae... | Maastricht, 10 January 2024
, the world-leading cell-cultured leather company, today announces a series of significant milestones in its journey towards commercial scale. The firm has secured investment from breakthrough VC’s
, marking a ... |
| 04.01.2024 | Matisse Pharmaceuticals closes EUR. 3.6 million financing round. | Geleen, 4 January 2024
,
The fresh new funding will allow Matisse to effectively continue its preparation for a large scale phase II study in sepsis patients. In the course of 2024, Matisse aims to conclude a series A funding round which ... |
| 04.01.2024 | Corporis Medical closes €4M series B financing round. | Maastricht, 7 December 2023
Corporis Medical focuses on the development and commercialization of innovative medical devices for minimally invasive surgery. Proceeds will be used to fund a Randomized Controlled Trial for Mediclose™, as well... |
| 04.01.2024 | AGI Group Acquires Chemtrix B.V. to Expand into the Large-scale Flow Chemistry Market. | Geleen, 4 January 2024
, based in the Netherlands, designs and manufactures a scalable portfolio of flow reactors that enables industry and academia to harness the advantages of flow chemistry and process intensification. This strategic ac... |
| 11.10.2023 | Luc Starmans promoted to Partner in Health Team BVP | Geleen, The Netherlands, 9 October 2023
, an impact venture capital firm based in the Netherlands, announced today the promotion of
, PhD, to
. Luc previously served as senior investment manager on the team, where he mainly focused on me... |
| 09.09.2023 | €1 Million Seed Investment Fuels ReSolved Technologies' Mission for Sustainable Recycling Solutions | The ReSolved Technologies team: Jean-Jacques Colin, Norbert Fraunholcz and Luca Loise
Geleen, The Netherlands, 28 August 2023
ReSolved Technologies specializes in solvent-based recycling, offering a solution for the closed-loop recycling ... |
| 07.07.2023 | Aliform secures a $1.7 million Seed investment to drive innovation in skin surgery. | Dallas, Texas, June 15, 2023
Aliform developed a technology which helps skin surgeons in treating a range of connective tissue problems in a safer and more cost-effective manner. “When it comes to skin surgery, minimizing damage is essenti... |
| 05.04.2023 | Optimal cartilage repair in the knee one step closer through second phase of clinical study Hy2Care’s CartRevive™ | Geleen, March 30, 2023
Hy2Care announced today that it will initiate the next phase of its ACTIVE clinical study to improve cartilage repair of the knee joint. After completing the first ‘safety’ group of 10 patients early 2023, the Medi... |
| 08.03.2023 | Sulzer acquires stake in Fuenix Ecogy and completes portfolio for plastic waste reduction | February 17, 2023
The partnership will drive the development, commercialization and adoption of advanced, fully integrated solutions for plastic waste processing. The move will allow Sulzer to offer complete recycling lines based on Fuenix... |
| 24.01.2023 | Exit: BioActor acquired by Solabia Group | The Netherlands, January 12 2023
Founded in 2011, BioActor is an innovation leader in the development and commercialisation of clinically evaluated polyphenols extracted from edible plants and fruits and used by leading food supplement bra... |
| 21.11.2022 | Circularise secures €11M in funding from Brightlands Venture Partners, Asahi Kasei, Neste, 4impact and others | Investment announcement at the Slush 2022 event
The Hague, The Netherlands, November 17 2022
The company’s mission is to support the shift from a linear to a circular economy. With its blockchain-based digital product passports, Circulari... |
| 01.11.2022 | Synaffix Licenses CliCr® Chemistry from Cristal Therapeutics to Fortify Best-in-Class ADC Technology Offering | Amsterdam, The Netherlands, October 18 2022
Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class thera... |
| 01.11.2022 | Greencovery raises € 500.000 to accelerate their unique separation-purification technology for upcycling food side streams | Wageningen, The Netherlands, October 20 2022
The food processing industry is constantly trying to reduce waste and looking for opportunities to valorize their side streams and develop new products. Carlos Cabrera, CEO and Co-founder of Gre... |
| 14.09.2022 | Koch Technology Solutions And Ioniqa Technologies Partner To Disrupt Plastics Industry Through Advanced PET Upcycling Technology | Please scroll down for Dutch version
September 13, 2022
Ioniqa has developed an innovative process that utilizes low-grade post-consumer PET to infinitely produce a feedstock that displaces virgin raw materials used in the production of p... |
| 11.09.2022 | Second orphan medicinal product designation for Neuro-Cells® paves way for application to both chronic and trauma-induced neurodegenerative diseases: Fast-track status is granted for frontotemporal de... | Geleen, The Netherlands, 8 September 2022
Several conditions of the central nervous system, even when they seem unrelated at first and may have distinctive causes, have similar underlying disease mechanisms in common. These include unprogr... |
| 11.09.2022 | Brightlands Venture Partners invests in AgTech company S+dB | Please scroll down for Dutch version
Nederweert, The Netherlands, 7 September 2022
S+dB developed a proprietary plant seed-embedding technology (SET) to guarantee an optimal germination environment for any type of plant seed; either in op... |
| 11.09.2022 | Matisse Pharmaceuticals about to start third dose level in a Phase I/IIa study with its lead compound M6229 in septic patients | Please scroll down for Dutch version
Geleen, The Netherlands, 7 September 2022
The primary objectives of the study are:
In the second cohort of the study, all subjects survived the 30-day follow-up, without any serious adverse events. Up... |
| 03.07.2022 | Verdify increases seed round to €2.1 million for accelerated rollout of personalised recipe platform |
Verdify has raised €800,000 on top of the €1.3 million in funding the company obtained last December. This brings the seed round to € 2.1 million in total. The additional capital will be provided by Brave New Food Investments and exis... |
| 24.06.2022 | Hy2Care receives € 6M EU funding for optimal cartilage repair | Geleen, The Netherlands, 9 June 2022
The EIC Accelerator is a highly competitive program of the European Commission offering funding, coaching and business acceleration services to innovative small or medium-sized businesses with a scalabl... |
| 21.04.2022 | Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells® treatment for Traumatic Spinal Cord Injury | Geleen, The Netherlands, 29 March 2022
Annually, approximately 29,000 people across Europe and the USA suffer from acute TSCI, for which effective treatment is currently unavailable. Patients usually experience life-long disability and dep... |
| 18.01.2022 | Mane Biotech raises € 1.7 million to further develop its regenerative medicine technology to combat hair loss | Please scroll down for Dutch version
Cologne, Germany, 18 January 2022
Mane Biotech is a biomedical company inspired by extensive research in regenerative medicine, software and engineering. It is developing an innovative solution that ... |
| 12.01.2022 | PectCof raises € 2million for its innovative coffee pulp-based food ingredients | Please scroll down for Dutch version
Venlo, The Netherlands, 12 January 2022
PectCof’s technology unlocks the full potential of coffee pulp and provides an enormous positive environmental and societal impact. The coffee pulp, the side str... |
| 25.11.2021 | Vertoro raises funding to scale up its Goldilocks® liquid lignin technology | Goldilocks® – a liquid lignin platform for fuel, chemical and material applications (
)
Please scroll down for Dutch version
Geleen, The Netherlands, 14 October 2021
Vertoro was founded in 2017 as a spin-off from Chemelot InSciTe and is... |
| 25.11.2021 | Approval from the Dutch Health Authorities to initiate a Phase I study with Matisse Pharmaceuticals’ lead compound M6229 in sepsis |
Geleen, The Netherlands, 10 November 2021
The approval to initiate this clinical study is a key milestone in the development of M6229. “We are excited to receive this approval and look forward to the outcome of this very important study ... |
| 25.11.2021 | Dutch stem cell biotech Neuroplast secures € 10 million (US$ 11.5 million) in Series B funding for further development of its transformative stem cell therapy for Traumatic Spinal Cord Injury | Geleen, The Netherlands, 17 November 2021
®
Annually, approximately 29,000 people across Europe and the USA suffer from acute Traumatic Spinal Cord Injury (TSCI), for which effective treatment is currently unavailable. Patients usually ... |
| 09.07.2021 | Qorium raises € 2.6 mln to further develop its truly sustainable cultivated leather technology | The management team at Qorium: Rutger Ploem, Stef Kranendijk, Mark Post.
Please scroll down for Dutch version
Maastricht, The Netherlands, 8 July 2021
Qorium is a biotechnology driven company aiming to provide the world with a premium, c... |
| 08.06.2021 | Groundbreaking treatment for type II endoleaks proves very successful | Please scroll down for Dutch version
Geleen, The Netherlands, 7 June 2021
As of today, 13 patients have been successfully treated with AneuFix without any major complications. By the end of this pivotal study a total of 25 patients will h... |
| 26.05.2021 | PL BioScience raises € 3.7 mln from Born2Grow, Brightlands Venture Partners, TechVision Fund I and more | The management team at PL BioScience: Dr. Hatim Hemeda, Dr. Siegfried Ebner, Christian Wilkes (from left). © PL BioScience / Alexander Sievert
Aachen, Germany, 25 May 2021
Brightlands Venture Partners invests in PL BioScience GmbH. This i... |
| 19.05.2021 | Ioniqa attracts € 10 million funding | Eindhoven, The Netherlands, 18 May 2021
In today’s market, governments, international brands and plastic producers are setting themselves steep targets for 100% recycled PET plastics, led by a major shift in consumer demands. This creates ... |
| 18.05.2021 | Black Bear Carbon raises € 7.5 million in a first closing for its new flagship plant |
Geleen, The Netherlands, 17 May 2021
“This financing is a crucial first step to allow BBC to scale up production and contribute to the development of a circular economy. We are delighted, this funding round couldn’t have come at a better... |
| 23.04.2021 | Brightlands Agrifood Fund provides growth capital to Kipster | Please scroll down for Dutch version
Venlo, The Netherlands, 22 April 2021
The international interest for the Dutch based Kipster concept is big. Scientists, policy makers, journalists and farmers travel from the US, Asia, Africa and Aust... |
| 16.04.2021 | Brightlands Venture Partners closes € 45M sustainability and health fund | Please scroll down for Dutch version
Geleen, The Netherlands, 15 April 2021
With its new fund, Brightlands Venture Partners will invest in startups and scaleups in the Netherlands, Belgium and North Rhine Westphalia, that will benefit fro... |
| 07.01.2021 | Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms | Bilthoven and Maastricht, The Netherlands, 6 January 2021
Under the terms of the agreement, Cristal Therapeutics and Intravacc will collaborate with an initial focus on generating a CriVac® vaccine candidate based on the receptor-binding d... |
| - | FD: Zo wordt oud plastic geld waard (Dutch) | The Dutch newspaper “Het Financieele Dagblad” has released an article on plastic recycling. It features our portfolio company Ioniqa. Read the full article in Dutch here: |
| - | Exit: Takeda Completes its Acquisition of TiGenix Following Expiration of the Squeeze-out Period | Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (“TiGenix”) today announced that Takeda has acquired all outstanding ordinary shares (“Ordinary Shares”) (including Ordinary Shares represented by American Deposita... |
| - | Brightlands Venture Partners: new name for fund manager of Limburg Ventures, Chemelot Ventures and Brightlands Agrifood Fund | Brightlands Venture Partners will be the new name for the team managing Limburg Ventures, Chemelot Ventures and Brightlands Agrifood Fund. Using the new umbrella name, the team reflects its preparations for a next venture capital fund focus... |
| - | €1,4 miljoen investering voor Materiomics, Brightlands Maastricht | Materiomics is gespecialiseerd in het vinden van oppervlaktestructuren die het gedrag van cellen beïnvloeden. Hierdoor verbetert de toepassing van het product en worden coatings overbodig. Materiomics kan heel veel verschillende oppervlakte... |
| - | Tech Tour interviews Casper Bruens on how more European companies can be scaled up | - |
| - | Patrick Claessen joins Chemelot Ventures as Sr. Investment Manager | We are very pleased to announce that Patrick Claessen will be joining the Chemelot Ventures team as a Senior Investment Manager starting May 1st 2016. He will be working out of the Brightlands Chemelot campus in Geleen. Before joining Cheme... |
| - | Cristal Therapeutics awarded €2.5M Horizon 2020 grant | In addition, the grant will support Cristal Therapeutics’ collaboration with various academic and commercial parties to generate clinical trial material and perform several preclinical mechanism of action studies.
CriPec®-docetaxel is a ne... |
| - | Ioniqa heeft de Ambitie 2020 Challenge gewonnen van MVO Nederland | Ioniqa heeft de Ambitie 2020 Challenge gewonnen van MVO Nederland. Dat werd gisteren bekendgemaakt tijdens de prijsuitreiking. Doelstelling van de Ambitie 2020 Challenge is ondernemers te stimuleren om met plannen te komen die bijdragen aan... |
| - | Out of over 13,000 innovators from over 90 countries, Black Bear secures a place in the 2019 Global Cleantech 100 | ,
, 2019. Black Bear, the Dutch tire-to-Carbon Black upcycling company, was named by Cleantech Group in the prestigious 2019 Global Cleantech 100. The Global Cleantech 100 is an annual guide to the leading companies and themes in sustainab... |
| - | Black Bear announces CEO transition |
Silvio Ghyoot (54) has a distinguished career in the petrochemical industry and has held many international management positions with Albemarle Corporation and other chemical companies. Most recently Silvio served as Executive Director of... |
| - | Coca-Cola Announces Loan Agreement with Ioniqa to Turn Hard-to-Recycle Plastic Waste into High-Quality PET |
ATLANTA–(BUSINESS WIRE)–The Coca-Cola Company today announced a new agreement extending a loan to Ioniqa Technologies (The Netherlands) to facilitate the development of Ioniqa’s proprietary technology to produce high-grade, recycled PET c... |
| - | Cristal and iTeos announce strategic partnership for the development of immuno-oncology candidates | Maastricht, The Netherlands and Gosselies, Belgium – December 7th, 2016 – Cristal Therapeutics, a Dutch privately-held life sciences company developing novel nanomedicines against cancer and other diseases and iTeos Therapeutics SA, a Belg... |
| - | Breakthrough Technology Takes Plastic From the Ocean and Uses It in a Coca-Cola Bottle |
LONDON–(BUSINESS WIRE)–The Coca-Cola Company unveiled its first-ever sample bottles made using recovered and recycled marine plastics, demonstrating that, one day, even ocean debris could be used in recycled packaging for food or drinks
... |
| - | Zo maak je een nieuwe autoband uit een oude | Onderstaand artikel is verschenen in de Volkskrant op 16 september 2016. Het auteursrecht is voorbehouden aan Peter de Graaf.
Als we van fossiele brandstoffen afwillen om de wereld beter te maken, kunnen we niet meer op de traditionele man... |
| - | Neuroplast raises € 4 million for its stem cell-based technology to treat patients with Spinal Cord Injury | Please scroll down for Dutch version
Geleen, The Netherlands, 11 February 2020
Neuroplast BV received equity funding from Dutch-based Brightlands Venture Partners and LIOF and from existing shareholder and informal investor Lumana Invest ... |
| - | TripleMed raises over € 2 mln for innovative treatment of aortic aneurysms | For the Dutch version of the press release please scroll down.
TripleMed recently completed the pre-clinical studies with very promising results. The €2 million Series A round enables TripleMed to perform clinical studies in aortic aneurys... |
| - | Lonza rejigs network to tap 'huge potential' of cell and gene therapies | Note: In 2017 Lonza acquired Pharmacell, a Limburg Ventures portfolio company located at the Brightlands Chemelot Campus in Geleen. Lonza plans to expand the site and make it the European Center of Excellence for its cell and gene therapy s... |
| - | Black Bear | Zes mannen, een war room en een missie met zwart poeder | Onderstaand artikel is verschenen in het Financieele Dagblad van zaterdag 28 april 2016. Het auteursrecht is voorbehouden aan Sabine Sluijters.
Black Bear maakt carbon black uit oude autobanden. Het zwarte poeder wordt als ingrediënt gebru... |
| - | Exit: Isobionics acquired by BASF | For Dutch please scroll down
The company was founded in 2008 by CEO Toine Janssen and Brightlands Venture Partners (via its Limburg Ventures fund). In subsequent financing rounds other investors joined: LIOF, Brabant Life Sciences Seed Fun... |
| - | FD: Chemische recyclingfabriek in Geleen (Dutch) | De startup Ioniqa Technologies in Eindhoven bouwt een recycling-fabriek in Geleen voor het omzetten van PET-afval. De installatie gaat producten met PET-plastics zoals flessen, verpakkingen, sportschoenen en fleecekleding, verwerken tot pur... |
| - | Black Bear raises 16 million Euro to solve the global waste tire problem and slash CO2 | Nederweert (Netherlands), 6.9.2018.
Six new partners have become stakeholders: The largest Dutch banking corporation ING Group, two Netherlands-based investment firms 5square and Social Impact Ventures, as well as the conglomerate SCG from... |
| - | Corporis Medical has been recently awarded a EUROSTAR grant | Corporis Medical, a medical device company located at the Brightlands Maastricht Health Campus, has formed a consortium with AIM BV (Netherlands), and CSEM SA (Switzerland) to further develop its Perfusion Measurement technology towards a c... |
| - | Agrifood gains access to Brightlands Fund | For Dutch version please scroll down.
This is a joint press release from the Province of Limburg, Rabobank Venlo, LIOF and Chemelot Ventures
The expansion is in the form of a separate entity, Brightlands Agrifood Ventures, which will be m... |
| - | Unilever to pioneer breakthrough food packaging technology together with Ioniqa & Indorama | Ioniqa has developed a proprietary technology that is able to convert any PET waste – including coloured packs – back into transparent virgin grade material. The technology has successfully passed its pilot stage and is now moving towards t... |
| - | Cristal Therapeutics appoints Dr Werner Cautreels as a new Director and Board Chairman and Andre Verwei as CFO | Cristal Therapeutics, a Phase 2 clinical stage pharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, announces that Dr Werner Cautreels is joining the Company’s... |
| - | BioActor and Nestlé Health Science to collaborate on nutritional products | www.bioactor.com
Maastricht, Netherlands/Vevey, Switzerland, 4 may 2015 – Today BioActor announced that it has engaged in a collaboration with Nestlé Health Science on the development of nutritional products containing Bonolive®.
Bonolive... |
| - | Fortimedix Surgical Announces Successful Completion of First-In-Man Laparoscopic Cholecystectomy | Two laparoscopic cholecystectomy procedures were performed through the umbilicus with the Fortimedix Surgical system by renowned surgeon Santiago Horgan, MD, professor of surgery and chief of minimally invasive surgery at UC San Diego Healt... |
| - | Health Value Creation raises €2 million for Innovative Surgical Devices | For Dutch please scroll down.
Located at the Brightlands Maastricht Health Campus, Health Value Creation, recently completed design and clinical research studies for its two innovative devices with very promising results. The first device ... |
| - | Black Bear Carbon in the spotlight: RTL news, RvO, fd en Trouw | [one_half]
[/one_half][one_half_last]
[/one_half_last]
[one_half]
BlackBear, een bedrijf dat oude autobanden een tweede leven geeft, heeft €11mln opgehaald om de onderneming uit te breiden en meer samenwerkingen in het buitenland aan te... |
| - | B. Braun Interventional Systems expands its congenital and structural heart portfolio with the Emeryglide MR Conditional Guidewire from Nano4Imaging | B. Braun Interventional Systems Inc. (BIS), a company dedicated to providing innovative solutions in the field of congenital and structural interventional cardiology, today announced it has signed an exclusive U.S. distribution agreement wi... |
| - | TiGenix positive Phase III results to be presented at Digestive Disease Week | The ADMIRE-CD Phase III 24-week positive results will be presented by Professor Julian Panés, Head of the Gastroenterology Department, at the Hospital Clinic of Barcelona and Chairman of the TiGenix ADMIRE-CD Scientific Advisory Board in Eu... |
| - | Circular PET Polyester recycling reaches 1,000 Liter scale | (this article first appeared on Ioniqa.com)
Eindhoven, The Netherlands, 20 April 2016
In the last few weeks several 1,000 liter runs were performed. Very crucial tests to proof that Ioniqa’s Magnetic Smart Process – used to upcycle all ki... |
| - | TiGenix selects TFS for the first clinical trial to treat severe sepsis | (This article first appeared on tfscro.com)
The SEPCELL project is a randomized, double-blind, placebo-controlled, Phase Ib/IIa study in severe sepsis secondary to severe CAP (sCAP). Subjects in the trial must have sCAP requiring mechanica... |
| - | AkzoNobel and Black Bear team up to make powder coatings from old tyres | Tyres that have reached the end of the road are being harvested for carbon black and used to produce powder coatings in a new cooperation between AkzoNobel and Dutch company Black Bear.
The Cradle-to-CradleTM certified carbon black supplie... |
| - | Vacis raises capital from Brightlands Venture Partners, HTGF, LIOF and RVO | Dominik Klump and Josephine Brackman examine a rod at Vacis’ InSciTe lab facilities
Please scroll down for the German and Dutch versions
Geleen, The Netherlands, 10 October 2019
The company received funding from Netherlands-based Brightl... |
| - | Brightlands Agrifood Ventures grows to € 20 mln in a second closing | Brightlands Agrifood Ventures has realized a second closing of its fund with three additional funding parties, each with a commitment of € 1 million. The three parties are LLTB (Limburgse Land- en Tuinbouwbond), Van Herk Ventures and an und... |
| - | Cristal Therapeutics starts phase I trial with nano-medicine CriPec® | Cristal Therapeutics has developed a pioneering approach to transform existing drugs against cancer, like docetaxel, and other diseases, into tailor-made nanoparticles via its proprietary polymeric technology, registered as CriPec
. The Cr... |
| - | Ioniqa Technologies and Chemelot Ventures announce funding for Ioniqa | www.ioniqa.com
7 September 2015, Eindhoven, The Netherlands – High-tech chemical company Ioniqa Technologies BV (Eindhoven, The Netherlands) and Chemelot Ventures BV announce that they have finalized a multi-million funding round for the u... |
| - | ChemConnection and Cristal Therapeutics Announce Successful GMP Production of CriPec® Docetaxel | “ChemConnection has made a tremendous leap forward in becoming the global lead center for nanomedicines manufacturing” said Gerjan Kemperman, CEO of ChemConnection. “Recent investments in our manufacturing and analytical capabilities have b... |
| - | Black Bear strengthens team with experienced sales executives | NEDERWEERT, The Netherlands, September 15, 2016 – Black Bear today announced that Ad van Oorschot en Serge Klunder have joined the Black Bear team to service our customers in the growing market for high quality, green carbon blacks.
Ad van... |
| - | Chemelot Ventures invests in Black Bear Carbon BV | Chemelot Ventures recently made an equity investment in Black Bear Carbon BV. Black Bear Carbon developed a process to turn used tires into carbon black and will soon open the first commercial plant. Carbon black is sold as an additive in r... |
| - | Black Bear Debuts World’s First Cradle to Cradle Certified™ Carbon Black | Black Bear announces that Black Bear’s carbon black has received an official Cradle to Cradle Certified™ Bronze Certificate, assessed by the Environmental Protection Encouragement Agency (EPEA). This is the first time that a carbon black ha... |
| - | One2Born en Ioniqa winnen Herman Wijffels Innovatieprijzen | Click on the link to read the press release:
|
| - | Fortimedix Surgical Closes €11M Round for Launch of Innovative Single-Port Surgical Platform | “We are proud to partner with Fortimedix Surgical as it launches FMX314, which we believe can deliver on the promise of single-port laparoscopic surgery,” commented Casper Bruens, Managing Director of Chemelot Ventures. “Since 2004 our firm... |
| - | Asparagus harvesting robot developer AvL Motion raises € 1 million from Brightlands Agrifood Fund, Future Food Fund and BOM | AvL’s Compact S1560 in action
Please scroll down for Dutch version
Westerbeek, The Netherlands, 11 December 2019
Intro movie: “The future of farming is
”
In April 2019 AvL Motion demonstrated its demo, the AvL Compact S1560 followed by... |
| - | Cristal Therapeutics Initiates Phase 2 Clinical Trial of CriPec® Nanomedicine Drug Candidate in Ovarian Cancer | –
, a clinical stage pharmaceutical company developing unique nanomedicines for the treatment of cancer and other diseases, announced today the first patient has been dosed in its Phase 2 clinical trial of lead nanomedicine candidate CPC63... |
| - | Thatchtec raises € 1.5 million from Brightlands Agrifood Fund and Future Food Fund to develop its biobased soil health technology | Wageningen, 28 April 2020
Thatchtec develops and markets groundbreaking biobased solutions for soil health improvement.
Ard Reijtenbagh, who joined Thatchtec as CEO in 2019: “In the past years, extensive research and successful commercial... |
| - | Grassa raises € 2 million for its innovative biorefinery process | For Dutch please scroll down
Grassa, founded in 2014, has developed a new, efficient biorefinery technology to process grass and vegetable waste. The process results in four products: roughage cattle feed, protein concentrate, fructooligos... |
| - | Matisse Pharmaceuticals secures a € 1.9 million financing round led by Chemelot Ventures | Sittard-Geleen (NL), 15 November 2016, Matisse Pharmaceuticals, a biotechnology company focused on the development of pharmaceuticals to treat disorders that are associated with fulminant inflammation such as sepsis, announces a € 1.9 milli... |
| - | Kriya in the spotlight: Roel Huis in ’t Veld - Pleased to meet you! | My name is Roel Huis in ’t Veld, I am the director of Kriya Materials B.V. located at the Brightlands Chemelot campus since 2006. Our company focuses on making novel nanotechnology-based-products which will have a positive impact on the amo... |
| - | Chemelot Ventures: aandeelhouder en sparringpartner | Bekijk de youtube video
De investeerder richt zich op bedrijven in de biochemie en biomaterialen, regeneratieve geneeskunde en diagnostiek en analyse. “Naast investeerder is Chemelot Ventures vooral een uitstekend klankbord en sparringpart... |
| - | Cristal Therapeutics Dr. Axel Mescheder appointed as CEO as focus intensifies on oncology nanomedicine pipeline | , 2nd November 2018 –
, a clinical stage pharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, has appointed Dr. Axel Mescheder to the role of Chief Executive ... |
| - | DSM and Chemtrix sign distributorship on 3D printed metal continuous flow reactors | The agreement brings together the expertise of both parties in the field of continuous flow chemistry to serve the chemical industry with this new type of flow reactors to facilitate fast process development, piloting and full scale product... |
| - | FABPulous BV Announces evolved Executive Management Team | 29th June 2015, Maastricht (Netherlands) – FABPulous BV today announced a restructure of its executive management team. The company, founded in 2008 by Professor Jan Glatz to develop point of care in vitro diagnostic (IVD) for the early det... |
| - | Cristal Therapeutics announces Jeroen Tonnaer as Chief Business Officer | www.cristaltherapeutics.com
Maastricht, The Netherlands, 21 April, 2015 – Cristal Therapeutics, a privately-held life sciences company developing novel nanotherapeutics against cancer and other diseases, by using its patented CriPec® platf... |
| - | Cristal Therapeutics raises €12.8 million in new financing round to advance novel medicines against cancer | -Round led by Aglaia BioMedical Ventures and DROIA Oncology Ventures
-Funding used:
-to execute clinical phase Ib and phase IIa trials with CriPec® docetaxel
-to further leverage the CriPec® platform for oligonucleotides programs fro... |
| - | Verdify raises € 1.3 million to scale its Swapmeals® platform for personalised recipes | Please scroll down for Dutch version
Venlo, The Netherlands, 13 December 2021
Verdify (Venlo, The Netherlands) has raised €1.3 million financing from Brightlands Venture Partners, Joles and the company’s founders. The investment will be u... |
| - | Black Bear strengthens technical team with an experienced coatings PhD | Strong focus on product development and providing excellent technical support to growing customer base
NEDERWEERT, The Netherlands, October 27, 2016 – Black Bear today announced that Patricia Geelen PhD, has joined the Black Bear team to h... |
| - | Dr. Istvan Udvaros joins Cristal Therapeutics as New Chief Medical Officer | Dr. Udvaros replaces previous CMO Dr. Edwin Klumper.
Welcoming Dr. Udvaros to the team, Dr. Joost Holthuis, Cristal Therapeutics’ CEO and Co- founder said,
Commenting on his appointment, Dr. Udvaros added,
Dr. Udvaros joins Cristal Thera... |
| - | FABPulous wins €1.6m EU grant for clinical trials, 5 minuteheart attack | July 20th 2015, Maastricht (Netherlands) – The European Union awarded FABPulous BV a €1.6 million Phase 2 grant to fund two clinical trials in the UK and Belgium/Netherlands and automate the manufacture of its 5 minute, patented H-FABP True... |
| - | Exit: Brightlands Venture Partners sells its stake in Polyscope Polymers | Polyscope Production Facility at the Chemelot Industrial Site in Geleen
For Dutch please scroll down
Polyscope Polymers recently finalized its integration of Total/Cray Valley’s SMA business. This business deal positions Polyscope as the ... |
| - | Vertoro receives Seed Financing from Chemelot Ventures and LIOF | Vertoro, which is located on the Brightlands Chemelot Campus in Geleen, is the outcome of a project by Chemelot InSciTe, a public-private partnership. An initial upscaling of the bio-oil has already been completed as part of this project. V... |
| - | Ioniqa launching first PET plastic up-cycling plant | Last April it was announced that Ioniqa had entered into a partnership with Unilever and PET packaging market leader Indorama. According to Tonnis Hooghoudt, CEO of Ioniqa, the cooperation with both multinationals is very important: “Since ... |
| - | Hy2Care raises € 3.7 mln for hydrogel technology to repair cartilage defects | Prof Marcel Karperien demonstrates the injection devised as it is used during an arthroscopic procedure to place the hydrogel into the patients’ cartilage defect. ©Emiel Muijderman
For Dutch version please scroll down
Enschede / Sittard-G... |
